Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: A systematic review and meta-analysis

JACC: Cardiovascular Interventions

Volumn 3, Issue 12, 2010, Pages 1262-1273

  Wiisanen, Matthew E ^a   Abdel Latif, Ahmed ^a   Mukherjee, Debabrata ^a   Ziada, Khaled M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

bare metal stent(s); drug eluting stent(s); meta analysis; percutaneous coronary intervention; saphenous vein graft

Indexed keywords

PACLITAXEL; RAPAMYCIN; TACROLIMUS;

BARE METAL STENT; CLINICAL TRIAL; DEVICE THERAPY; DRUG EFFICACY; DRUG ELUTING STENT; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR ADVERSE CARDIAC EVENT; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; SYSTEMATIC REVIEW; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 78651412362     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.08.019     Document Type: Article

References (54)

1. M. Singh, C.S. Rihal, R.J. Lennon, K.N. Garratt, V. Mathew, and D.R. Holmes Jr. Prediction of complications following nonemergency percutaneous coronary interventions Am J Cardiol 96 2005 907 912
2. M.P. Savage, J.S. Douglas Jr., D.L. Fischman Saphenous Vein De Novo Trial Investigators Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med 337 1997 740 747
3. D.S. Baim, D. Wahr, and B. George Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 105 2002 1285 1290
4. G.W. Stone, C. Rogers, and J. Hermiller Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts Circulation 108 2003 548 553
5. L. Campeau, M. Enjalbert, J. Lesperance, C. Vaislic, C.M. Grondin, and M.G. Bourassa Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery Circulation 68 1983 II1 II7
6. G.M. Fitzgibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
7. S. Goldman, K. Zadina, and T. Moritz Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study J Am Coll Cardiol 44 2004 2149 2156
8. N.W. Salomon, U.S. Page, J.C. Bigelow, A.H. Krause, J.E. Okies, and M.T. Metzdorff Reoperative coronary surgery Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass J Thorac Cardiovasc Surg 100 1990 250 259 discussion 25960
9. C. Kaiser, H.P. Brunner-La Rocca, and P.T. Buser Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET) Lancet 366 2005 921 929
10. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
11. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
12. D. Stroup, J. Berlin, S. Morton Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group Meta-analysis of observational studies in epidemiology: a proposal for reporting JAMA 283 2000 2008 2012
13. D. Moher, J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Lancet 354 1999 1896 1900
14. H. Sacks, T.C. Chalmers, and H. Smith Jr. Randomized versus historical controls for clinical trials Am J Med 72 1982 233 240
15. P. Juni, D. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
16. G. Wells, B. Shea, and D. O'Connell The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis 2005 Ottawa Health Research Institute Ottawa, Canada http://www.ohri.ca/programs/clinical- epidemiology/nosgen.doc Accessed February 19, 2010
17. B.R. Brodie, H. Wilson, and T. Stuckey Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group J Am Coll Cardiol Intv 2 2009 1105 1112
18. W.W. Chu, S.W. Rha, and P.K. Kuchulakanti Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention Am J Cardiol 97 2006 34 37
19. R. Hoffmann, T. Pohl, R. Koster, R. Blindt, P. Boeckstegers, and T. Heitzer Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study Heart 93 2007 331 334 (Pubitemid 46579523)
20. S. Kaplan, P. Barlis, A. Kiris, K. Dimopoulos, S. Celik, and C. Di Mario Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions Acute Card Care 10 2008 88 92
21. M.S. Lee, A.P. Shah, and J. Aragon Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts Catheter Cardiovasc Interv 66 2005 507 511
22. R.M. Minutello, S. Bhagan, and A. Sharma Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease J Interv Cardiol 20 2007 458 465
23. T. Okabe, J. Lindsay, and A.N. Buch Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts Am J Cardiol 102 2008 530 534
24. R.K. Ramana, A. Ronan, and K. Cohoon Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Catheter Cardiovasc Interv 71 2008 886 893
25. P.H. van Twisk, J. Daemen, N. Kukreja, R.T. van Domburg, and P.W. Serruys Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts EuroIntervention 4 2008 311 317
26. P. Vermeersch, P. Agostoni, and S. Verheye Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial J Am Coll Cardiol 48 2006 2423 2431
27. J. Wohrle, T. Nusser, H.A. Kestler, M. Kochs, and V. Hombach Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions Clin Res Cardiol 96 2007 70 76
28. D. Bansal, R. Muppidi, and S. Singla Percutaneous intervention on the saphenous vein bypass graftslong-term outcomes Catheter Cardiovasc Interv 71 2008 58 61
29. E.S. Brilakis, C. Lichtenwalter, and J.A. de Lemos A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
30. G. Gioia, A. Benassi, R. Mohendra, K. Chowdhury, I. Masood, and W. Matthai Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts Catheter Cardiovasc Interv 72 2008 13 20
31. N.J. Goswami, M. Gaffigan, and G. Berrio Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the prairie "Real World" Stent Registry Catheter Cardiovasc Interv 75 2010 93 100
32. R.V. Jeger, S. Schneiter, and C. Kaiser Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions Cardiology 112 2009 49 55
33. A. Assali, Y. Raz, and H. Vaknin-Assa Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions EuroIntervention 4 2008 108 114
34. T. Okabe, G.S. Mintz, and S.Y. Lee Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events J Invasive Cardiol 20 2008 635 639
35. L. Vignali, F. Saia, and A. Manari Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry) Am J Cardiol 101 2008 947 952
36. M.H. Shishehbor, R. Hawi, and I.M. Singh Drug-eluting versus bare-metal stents for treating saphenous vein grafts Am Heart J 158 2009 637 643
37. L. Ge, I. Iakovou, and J. Cosgrave Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions Eur Heart J 26 2005 1056 1062
38. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
39. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
40. J. Higgins, S. Thompson, J. Deeks, and D. Altman Measuring inconsistency in meta-analysis BMJ 327 2003 557 560
41. P. Vermeersch, P. Agostoni, and S. Verheye Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial J Am Coll Cardiol 50 2007 261 267
42. S.G. Ellis, D. Kandzari, and D.J. Kereiakes Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study J Invasive Cardiol 19 2007 404 409
43. L. Ge, I. Iakovou, and G.M. Sangiorgi Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome J Am Coll Cardiol 45 2005 989 994
44. I. Lozano, T. Garcia-Camarero, and P. Carrillo [Comparison of drug-eluting and bare metal stents in saphenous vein grafts Immediate and long-term results.] Rev Esp Cardiol 62 2009 39 47
45. A.J. Kirtane, A. Gupta, and S. Iyengar Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
46. M.N. Babapulle, L. Joseph, P. Belisle, J.M. Brophy, and M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
47. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
48. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
49. I. Varghese, J. Samuel, S. Banerjee, and E.S. Brilakis Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery Cardiovasc Revasc Med 10 2009 103 109
50. A. Budaj, S. Yusuf, and S.R. Mehta Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
51. E.M. Mahoney, S. Mehta, and Y. Yuan Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation Am Heart J 151 2006 219 227
52. R. Tung, S. Kaul, G.A. Diamond, and P.K. Shah Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence Ann Intern Med 144 2006 913 919
53. A. Coolong, D.S. Baim, and R.E. Kuntz Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients Circulation 117 2008 790 797
54. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 216 235